Healthcare Global Enterprises Completes Dispatch of Rights Issue Documents

Healthcare Global Enterprises Limited has completed the dispatch of its Letter of Offer for a significant rights issue, marking a key milestone in the company's capital raising initiative. The oncology-focused healthcare provider published mandatory newspaper advertisements on March 6, 2026, confirming compliance with SEBI regulations for its upcoming rights offering. Rights Issue Overview The company's rights issue presents substantial details for eligible shareholders: Parameter: Details Issue Size: Up to 8,294,566 equity shares Face Value: ₹10.00 per share Issue Price: ₹512.00 per share Premium: ₹502.00 per share Total Value: Up to ₹42,468.18 lakhs Subscription Ratio: 1:17 Record Date: March 2, 2026 Key Timeline and Dates The rights issue follows a structured timeline with specific dates for various activities: Event: Date Issue Opens: March 11, 2026 Last Date for On-Market Renunciation: March 20, 2026 Issue Closes: March 25, 2026 Dispatch Completion: March 4, 2026 Regulatory Compliance and Publication Healthcare Global Enterprises fulfilled its regulatory obligations by publishing advertisements in three newspapers with wide circulation on March 6, 2026. The publications included Financial Express (English national daily), Jansatta (Hindi national daily), and Vishwavanani (Kannada daily newspaper for the regional language of Bengaluru). This publication complies with sub-regulation (1) of Regulation 84 of the SEBI ICDR Regulations. Application Process and Requirements The rights issue mandates the use of ASBA (Applications Supported by Blocked Amount) process for all applications. Eligible equity shareholders holding shares in physical form must provide demat account details at least two working days before the issue closing date. The company has arranged with NSDL and CDSL for crediting rights entitlements under ISIN: INE075I01017. Document Availability and Access The Letter of Offer dated February 24, 2026, along with application forms and rights entitlement letters, has been dispatched to eligible shareholders. Electronic copies were sent to shareholders who provided valid email addresses, while physical copies were dispatched to Indian addresses on a reasonable effort basis. The documents are accessible on the company's website, registrar's portal, and stock exchange websites. Trading and Listing Information Existing equity shares trade on BSE (Scrip Code: 539787) and NSE (Symbol: HCG). Rights entitlements will be tradable in dematerialized form with a market lot of one rights entitlement during the renunciation period from March 11 to March 20, 2026. HealthCare Global Enterprises Limited has announced the record date of March 2, 2026 for its upcoming rights issue worth ₹42,500.00 lakhs. The company's board of directors, in their meeting held on February 24, 2026, approved the detailed terms and timeline for the equity fundraising initiative under Regulations 30 and 42 of the SEBI Listing Regulations. Rights Issue Structure and Pricing The rights issue comprises 82,94,566 fully paid-up equity shares with a face value of ₹10.00 each. The company has set the rights issue price at ₹512.00 per share, which includes a premium of ₹502.00 per equity share. Parameter: Details Total Shares Offered: 82,94,566 Issue Price: ₹512.00 per share Premium: ₹502.00 per share Face Value: ₹10.00 per share Total Amount: ₹42,468.18 lakhs Rights Ratio: 1:17 Entitlement and Record Date Details Shareholders holding equity shares as on the record date of March 2, 2026 will be entitled to participate in the rights issue. The entitlement ratio has been set at 1 rights equity share for every 17 fully paid-up equity shares held on the record date. Rights entitlements will be credited to eligible shareholders' demat accounts under ISIN INE075I20017 prior to the issue opening date. Issue Timeline and Key Dates The rights issue follows a structured timeline spanning from March 2026 to April 2026: Event: Date Record Date: Monday, March 2, 2026 Last Date for Credit of Rights Entitlements: Wednesday, March 4, 2026 Issue Opening Date: Wednesday, March 11, 2026 Last Date for On-Market Renunciation: Friday, March 20, 2026 Issue Closing Date: Wednesday, March 25, 2026 Finalisation of Basis of Allotment: Friday, March 27, 2026 Date of Allotment: Friday, March 27, 2026 Date of Credit of Rights Equity Shares: Monday, March 30, 2026 Date of Listing of Rights Equity Shares: Wednesday, April 1, 2026 Renunciation and Application Process Rights entitlement holders can renounce their rights either through on-market renunciation via stock exchanges or through off-market transfers. The company has made arrangements with NSDL and CDSL for crediting rights entitlements to eligible shareholders' demat accounts. To receive allotment, rights entitlement holders must submit applications by the issue closing date with full payment. If no application is made by the issue closing date, the rights entitlements will lapse. Impact on Share Capital The rights issue will increase the company's outstanding equity shares from 141,007,637 shares to 149,302,203 shares, assuming full subscription. The board retains the right to extend the issue period up to 30 days from the opening date if required. Regulatory Compliance The rights issue has been structured in accordance with the Companies Act 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, and SEBI Listing Regulations. The company will file the Letter of Offer with SEBI, BSE Limited, and National Stock Exchange of India Limited as part of the regulatory process. The board meeting commenced at 5.00 p.m. and completed at 7.50 p.m. on February 24, 2026. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.